Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pharmaceutical Statistics|December 21, 2023
Cautionary note on regional consistency evaluation in multiregional clinical trials with binary outcomesGosuke HommaPharmaceutical Statistics|December 13, 2019
Sequential parallel comparison design with two coprimary endpointsGosuke Homma, Takashi DaimonStatistics in Medicine|January 22, 2026
Analytical Evaluation of the 2-in-1 Adaptive Design for Binary EndpointsGosuke Homma, Takuma YoshidaClinical Trials (London, England)|January 11, 2023
Usefulness of the placebo lead-in design for clinical trials with binary outcomesGosuke Homma, Takashi DaimonStatistical Methods in Medical Research|August 29, 2025
Exact power and sample size in clinical trials with two co-primary binary endpointsGosuke Homma, Takuma YoshidaPharmaceutical Statistics|January 24, 2024
Sample size calculation in clinical trials with two co-primary endpoints including overdispersed count and continuous outcomesGosuke Homma, Takuma YoshidaPharmaceutical Statistics|November 10, 2018
A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomesGosuke Homma, Takashi DaimonBiometrical Journal. Biometrische Zeitschrift|August 29, 2019
Sequential parallel comparison design for "gold standard" noninferiority trials with a prespecified marginGosuke Homma, Takashi DaimonHeadache|May 15, 2021
Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patientsFumihiko Sakai, Takao Takeshima, Gosuke Homma, et al.Diabetes, Obesity & Metabolism|August 25, 2023
Efficacy and safety of the sodium-glucose co-transporter-2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double-blind, placebo-controlled, 52-week clinical trial (EMPA-ELDERLY)Daisuke Yabe, Kosuke Shiki, Gosuke Homma, et al.Pageof 2